mCRPC
![Talazoparib Plus Enzalutamide for HRR Gene-Altered mCRPC Receives FDA Approval](https://pharmtales.com/wp-content/uploads/2023/06/Talazoparib-Plus-Enzalutamide-for-HRR-Gene-Altered-mCRPC-Receives-FDA-Approval.jpg)
Talazoparib Plus Enzalutamide for HRR Gene-Altered mCRPC Receives FDA Approval
SG Tylor
Source – FDA On June 20, 2023, the combination of talazoparib (Talzenna) and enzalutamide (Xtandi) has been approved by the ...
Source – FDA On June 20, 2023, the combination of talazoparib (Talzenna) and enzalutamide (Xtandi) has been approved by the ...